Product
Wegovy (semaglutide) tablets
Once-daily oral semaglutide tablet from Novo Nordisk, FDA-approved December 2025 for weight management and cardiovascular risk reduction in adults. Self-pay $149 to $299/month by…
$149/mo
Wegovy (semaglutide) injection
Once-weekly semaglutide injection from Novo Nordisk. FDA-approved for chronic weight management, cardiovascular risk reduction and noncirrhotic MASH with fibrosis. Self-pay from $349/month via NovoCare Pharmacy (checked Sept 20, 2026).
At a glance
Self-pay from
$349/mo
standard price, before insurance
How it is taken
Subcutaneous injection, once weekly
FDA status
FDA-approved
Data last checked
September 20, 2026
Verified
FDA-approved for
- Chronic weight management (adults with obesity or overweight with a weight-related condition, and children 12 and older with obesity)
- Reduction of major cardiovascular event risk in adults with established heart disease and obesity or overweight
- Noncirrhotic MASH with moderate to advanced liver fibrosis in adults (accelerated approval, August 2025)
Boxed warning: Risk of thyroid C-cell tumors (see Prescribing Information). Read the Prescribing Information. This page is not medical advice. Talk to a licensed clinician.
Self-pay price by dose
$349
0.25 mg to 2.4 mg
$399
Wegovy HD 7.2 mg
-
0.25 mg to 2.4 mg$349/mo
- 1 box of 4 pens (one month)
- Same price at every standard dose: 0.25, 0.5, 1, 1.7 and 2.4 mg
- Free home delivery or local pharmacy pickup
-
Wegovy HD 7.2 mg$399/mo
- 1 box of 4 pens (one month)
- Free home delivery or local pharmacy pickup
Verified on September 20, 2026. Source: NovoCare Pharmacy (novocare.com). Prices can change, so confirm the final price before you pay.
Other ways to pay
Introductory self-pay offer
$199/month for 0.25 mg and 0.5 mg, first 2 monthly fills, for patients new to NovoCare or the Wegovy Savings Offer, through Dec 31, 2026 (checked Sept 20, 2026)
Commercial insurance savings
As little as $25/month with the savings offer (maximum $100/month savings; government beneficiaries excluded)
FSA/HSA
Accepted at NovoCare Pharmacy
Shipping
Free (NovoCare Pharmacy)
How the price compares
Lowest standard self-pay price per month from each manufacturer’s own pharmacy. Introductory offers and insurance prices are excluded. Medications, doses and approved uses differ, so this is a price reference, not a treatment comparison.
Key facts
- Medication class
- GLP-1 receptor agonist
- Active ingredient
- Semaglutide
- Manufacturer
- Novo Nordisk
- Dosage form
- Prefilled injection pen
- Available strengths
- 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg; Wegovy HD 7.2 mg
- Prescription required
- Yes
- Self-pay pharmacy
- NovoCare Pharmacy (home delivery or local pharmacy pickup)
About this medication
Wegovy injection is a once-weekly semaglutide medicine made by Novo Nordisk. It is FDA-approved, alongside a reduced-calorie diet and increased physical activity, for chronic weight management, for reducing the risk of major cardiovascular events in adults with established heart disease and obesity or overweight, and (under accelerated approval granted in August 2025) for noncirrhotic MASH with moderate to advanced liver fibrosis in adults.
Self-pay patients can buy Wegovy through NovoCare Pharmacy, Novo Nordisk’s direct-to-patient pharmacy, at the prices listed on this page. Prices were checked on September 20, 2026 and can change at any time. Wegovy requires a prescription from a licensed healthcare provider. Read the full Prescribing Information, including the boxed warning, before use.